Skip to main content
. 2016 Sep 5;16(1):174. doi: 10.1186/s12872-016-0340-1

Table 2.

Relationships between the quartiles of HFABP and the incidence of AKI, levels of cardiac markers and in-hospital mortality

Q1 Q2 Q3 Q4
H-FABP≦6.2 (n = 124) 6.3≦H-FABP≦11.6 (n = 123) 11.7≦H-FABP≦27.8 (n = 124) 27.9≦H-FABP (n = 123) p value
Acute kidney injury
 no-AKI (yes, %) 113 (91.1 %) 102 (82.9 %) 90 (72.6 %) 44 (35.8 %) <0.001
 Class R (yes, %) 9 (7.3 %) 16 (13.0 %) 23 (18.5 %) 35 (28.5 %) <0.001
 Class I (yes, %) 1 (0.8 %) 5 (4.1 %) 6 (4.8 %) 24 (19.5 %) <0.001
 Class F (yes, %) 1 (0.8 %) 0 (0.0 %) 5 (4.0 %) 20 (16.3 %) <0.001
Biomarkers
 hs-TropT (ng/ml) 0.02 (0.01–0.03) 0.04 (0.02–0.06) 0.06 (0.03–0.10) 0.14 (0.06–0.54) <0.001
 Nt-proBNP (pg/ml) 351 (68–1,748) 2,401 (925–5,451) 5,739 (1,991–13,267) 7929 (2,164–23,269) <0.001
In-hospital mortality
 dead (yes, %) 3 (2.4 %) 5 (4.1 %) 18 (14.5 %) 38 (30.9 %) <0.001

H-FABP heart-type fatty acid binding, LVEF left ventricular ejection fraction measured on echocardiography; WBC white blood cell; BUN blood urea nitrogen, BS blood sugar, CRP C-reactive protein, BNP brain natriuretic peptide, hs-TropT high-sensitivity troponin T, Nt-proBNP N-Terminal pro-brain-type natriuretic peptide, hs-CRP high-sensitivity C-reactive protein, NPPV noninvasive positive pressure ventilation, ETI endotracheal intubation, IABP intra-aortic balloon pumping, PCPS percutaneous cardiopulmonary support, CHDF continuous hemodiafiltration, ICU intensive care unit

p value between the quartiles of H-FABP determined using a variance analysis and the Kruskal-Wallis test